IL163781A0 - Purine derivatives as kinase inhibitors - Google Patents
Purine derivatives as kinase inhibitorsInfo
- Publication number
- IL163781A0 IL163781A0 IL16378103A IL16378103A IL163781A0 IL 163781 A0 IL163781 A0 IL 163781A0 IL 16378103 A IL16378103 A IL 16378103A IL 16378103 A IL16378103 A IL 16378103A IL 163781 A0 IL163781 A0 IL 163781A0
- Authority
- IL
- Israel
- Prior art keywords
- kinase inhibitors
- purine derivatives
- purine
- derivatives
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36224502P | 2002-03-05 | 2002-03-05 | |
PCT/US2003/005050 WO2003076442A1 (en) | 2002-03-05 | 2003-03-04 | Purine derivatives as kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL163781A0 true IL163781A0 (en) | 2005-12-18 |
Family
ID=27805149
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16378103A IL163781A0 (en) | 2002-03-05 | 2003-03-04 | Purine derivatives as kinase inhibitors |
IL163781A IL163781A (en) | 2002-03-05 | 2004-08-26 | Purine derivatives as kinase inhibitors |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL163781A IL163781A (en) | 2002-03-05 | 2004-08-26 | Purine derivatives as kinase inhibitors |
Country Status (16)
Country | Link |
---|---|
US (4) | US7491716B2 (xx) |
EP (1) | EP1483265B1 (xx) |
JP (1) | JP4414232B2 (xx) |
KR (1) | KR100974770B1 (xx) |
CN (1) | CN1312154C (xx) |
AT (1) | ATE346070T1 (xx) |
AU (1) | AU2003215325B8 (xx) |
BR (1) | BR0308243B1 (xx) |
CA (1) | CA2477967C (xx) |
CY (1) | CY1109006T1 (xx) |
DE (1) | DE60309848T2 (xx) |
DK (1) | DK1483265T3 (xx) |
ES (1) | ES2276048T3 (xx) |
IL (2) | IL163781A0 (xx) |
PT (1) | PT1483265E (xx) |
WO (1) | WO2003076442A1 (xx) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA04008671A (es) * | 2002-03-08 | 2004-12-06 | Lilly Co Eli | Derivados de pirrol-2,5-diona y su uso como inhibidores de gsk-3. |
GB0212049D0 (en) * | 2002-05-24 | 2002-07-03 | Merck Sharp & Dohme | Therapeutic agents |
ZA200706530B (en) | 2005-02-09 | 2009-01-28 | Arqule Inc | Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer |
EP1879591B8 (en) * | 2005-05-04 | 2012-04-04 | DeveloGen Aktiengesellschaft | Use of azapaullones for preventing and treating pancreatic autoimmune disorders |
US20080207594A1 (en) * | 2005-05-04 | 2008-08-28 | Davelogen Aktiengesellschaft | Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | ムスカリン性受容体調節による神経発生 |
AU2006304787A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
TW200800203A (en) | 2006-03-08 | 2008-01-01 | Astrazeneca Ab | New use |
ES2427247T3 (es) * | 2006-03-13 | 2013-10-30 | Kyorin Pharmaceutical Co., Ltd. | Aminoquinolonas como inhibidores de GSK-3 |
EP1845098A1 (en) * | 2006-03-29 | 2007-10-17 | Ferrer Internacional, S.A. | Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands |
EP2377531A2 (en) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
AU2007283113A1 (en) | 2006-08-08 | 2008-02-14 | Sanofi-Aventis | Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
CN101302216B (zh) * | 2007-05-11 | 2011-08-10 | 上海睿智化学研究有限公司 | 稠环吲哚类化合物的制备方法 |
AU2008268613A1 (en) | 2007-06-22 | 2008-12-31 | Arqule, Inc. | Quinazolinone compounds and methods of use thereof |
CN101801961B (zh) | 2007-06-22 | 2014-09-24 | 艾科尔公司 | 吡咯烷酮、吡咯烷-2,5-二酮、吡咯烷和硫代琥珀酰亚胺衍生物、组合物以及治疗癌症的方法 |
CA2690782C (en) | 2007-06-22 | 2016-02-02 | Arqule, Inc. | Compositions and methods for treatment of cancer |
TWI428132B (zh) | 2007-07-02 | 2014-03-01 | Lilly Co Eli | 癌症化療效果之強化 |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
JP5699129B2 (ja) | 2009-04-14 | 2015-04-08 | イーライ リリー アンド カンパニー | 造血器新生物および白血病の治療のためのベンゾジアゼピン誘導体 |
CA2771278A1 (en) | 2009-08-26 | 2011-03-03 | Sanofi | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
MX2012004990A (es) | 2009-10-30 | 2012-06-12 | Janssen Pharmaceutica Nv | Deribados de imidazo [1,2-b] pirimideazina y su uso como inhibidores de la enzima fosfodiesterasa 10. |
US8563567B2 (en) | 2009-12-30 | 2013-10-22 | Arqule, Inc. | Substituted heterocyclic compounds |
KR20120120307A (ko) | 2010-01-19 | 2012-11-01 | 아스트라제네카 아베 | 피라진 유도체 |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
US8470786B2 (en) * | 2010-12-23 | 2013-06-25 | Arqule, Inc. | Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120057A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8809324B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
US8809325B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120058A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
BR112013033375B1 (pt) | 2011-06-27 | 2022-05-10 | Janssen Pharmaceutica N.V | Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxa-lina, seu uso, composição farmacêutica que os compreende, processo de preparação dos mesmos, solução estéril e composto intermediário |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
CN104411312B (zh) | 2012-06-26 | 2018-03-06 | 詹森药业有限公司 | 包括pde2抑制剂例如1‑芳基‑4‑甲基‑[1,2,4]***[4,3‑a]‑喹喔啉化合物和pde10抑制剂的用于在治疗神经病学障碍或代谢障碍中使用的组合 |
MX362197B (es) | 2012-07-09 | 2019-01-08 | Janssen Pharmaceutica Nv | Derivados de imidazo[1,2-b]piridazina e imidazo[1,2-a]pirazina como inhibidores de la fosfodiesterasa 10; y el uso de los mismos en el tratamiento de trastornos neurológicos, psiquiátricos y metabólicos. |
WO2014098000A1 (en) * | 2012-12-17 | 2014-06-26 | Daiichi Sankyo Company, Limited | Process for preparation of a tricyclic heterocycle |
EP3015468A4 (en) | 2013-06-26 | 2017-02-22 | Daiichi Sankyo Co., Ltd. | Method for producing tricyclic heterocyclic compound |
EP2818471A1 (en) * | 2013-06-27 | 2014-12-31 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Nitrogen bicyclic compounds as inhibitors for Scyl1 and Grk5 |
KR20190104359A (ko) | 2016-12-30 | 2019-09-09 | 프리퀀시 테라퓨틱스, 인크. | 줄기/전구체 지지 세포의 자가 재생을 유도하기 위한 1h-피롤-2,5-다이온 화합물 및 이의 사용 방법 |
EP3609998A1 (en) | 2017-04-11 | 2020-02-19 | Frequency Therapeutics, Inc. | Methods for hair follicle stem cell proliferation |
WO2019126686A1 (en) * | 2017-12-21 | 2019-06-27 | Frequency Therapeutics, Inc. | 1,2-dihydro-3h-pyrazol-3-one compounds and methods of using same |
US10526343B2 (en) | 2018-03-26 | 2020-01-07 | University Of Sharjah | Heterocyclic systems and pharmaceutical applications thereof |
US20200121681A1 (en) | 2018-10-17 | 2020-04-23 | Frequency Therapeutics, Inc. | Methods for hair follicle stem cell proliferation |
US20220133740A1 (en) | 2019-02-08 | 2022-05-05 | Frequency Therapeutics, Inc. | Valproic acid compounds and wnt agonists for treating ear disorders |
CN112390794B (zh) * | 2019-08-19 | 2023-05-26 | 鲁南制药集团股份有限公司 | 一种米诺膦酸关键中间体的制备方法 |
CN115925622A (zh) * | 2023-02-10 | 2023-04-07 | 山西永津集团有限公司 | 一种3-氰基吡啶-2-基氨基甲酸叔丁酯的合成方法 |
CN115974850A (zh) * | 2023-02-16 | 2023-04-18 | 中国药科大学 | 一类作为akr1c3抑制剂的化合物及其制备方法与用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ280738B6 (cs) | 1988-02-10 | 1996-04-17 | F. Hoffmann - La Roche And Co., Aktiengesellschaft | Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi |
GB8904161D0 (en) | 1989-02-23 | 1989-04-05 | Hoffmann La Roche | Substituted pyrroles |
US6153618A (en) * | 1996-10-11 | 2000-11-28 | Chiron Corporation | Inhibitors of glycogen synthase 3 kinase |
GB9828640D0 (en) | 1998-12-23 | 1999-02-17 | Smithkline Beecham Plc | Novel method and compounds |
AU2072201A (en) * | 1999-12-16 | 2001-06-25 | Eli Lilly And Company | Agents and methods for the treatment of proliferative diseases |
ES2220585T3 (es) * | 1999-12-16 | 2004-12-16 | Eli Lilly And Company | Agentes y procedimiento para el tratamiento de enfermedades proliferativas. |
CA2417277A1 (en) | 2000-07-27 | 2002-02-07 | F. Hoffmann-La Roche Ag | 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3.beta. |
ATE326464T1 (de) | 2000-12-08 | 2006-06-15 | Ortho Mcneil Pharm Inc | Indazolyl-substituierte pyrrolidin-verbindungen als kinase inhibitoren |
ATE301661T1 (de) | 2000-12-08 | 2005-08-15 | Ortho Mcneil Pharm Inc | Makroheterocyclische verbindungen als kinase inhibitoren |
-
2003
- 2003-03-04 ES ES03711146T patent/ES2276048T3/es not_active Expired - Lifetime
- 2003-03-04 DK DK03711146T patent/DK1483265T3/da active
- 2003-03-04 KR KR1020047013828A patent/KR100974770B1/ko not_active IP Right Cessation
- 2003-03-04 BR BRPI0308243-1A patent/BR0308243B1/pt not_active IP Right Cessation
- 2003-03-04 CA CA2477967A patent/CA2477967C/en not_active Expired - Fee Related
- 2003-03-04 AT AT03711146T patent/ATE346070T1/de active
- 2003-03-04 WO PCT/US2003/005050 patent/WO2003076442A1/en active IP Right Grant
- 2003-03-04 DE DE60309848T patent/DE60309848T2/de not_active Expired - Lifetime
- 2003-03-04 AU AU2003215325A patent/AU2003215325B8/en not_active Ceased
- 2003-03-04 US US10/506,459 patent/US7491716B2/en not_active Expired - Fee Related
- 2003-03-04 JP JP2003574659A patent/JP4414232B2/ja not_active Expired - Fee Related
- 2003-03-04 EP EP03711146A patent/EP1483265B1/en not_active Expired - Lifetime
- 2003-03-04 CN CNB03805292XA patent/CN1312154C/zh not_active Expired - Fee Related
- 2003-03-04 IL IL16378103A patent/IL163781A0/xx unknown
- 2003-03-04 PT PT03711146T patent/PT1483265E/pt unknown
-
2004
- 2004-08-26 IL IL163781A patent/IL163781A/en not_active IP Right Cessation
-
2007
- 2007-01-18 CY CY20071100071T patent/CY1109006T1/el unknown
-
2008
- 2008-12-12 US US12/333,775 patent/US8022065B2/en not_active Expired - Fee Related
-
2011
- 2011-05-04 US US13/100,618 patent/US8058425B2/en not_active Expired - Fee Related
- 2011-08-09 US US13/206,057 patent/US20110294792A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20050090483A1 (en) | 2005-04-28 |
KR20040087338A (ko) | 2004-10-13 |
US7491716B2 (en) | 2009-02-17 |
CA2477967C (en) | 2010-08-10 |
US20110207721A1 (en) | 2011-08-25 |
US20110294792A1 (en) | 2011-12-01 |
AU2003215325A1 (en) | 2003-09-22 |
PT1483265E (pt) | 2007-01-31 |
ATE346070T1 (de) | 2006-12-15 |
DE60309848T2 (de) | 2007-05-16 |
BR0308243A (pt) | 2005-01-11 |
CY1109006T1 (el) | 2014-07-02 |
ES2276048T3 (es) | 2007-06-16 |
EP1483265A1 (en) | 2004-12-08 |
JP4414232B2 (ja) | 2010-02-10 |
US20090105229A1 (en) | 2009-04-23 |
DK1483265T3 (da) | 2007-03-19 |
DE60309848D1 (de) | 2007-01-04 |
BR0308243B1 (pt) | 2014-08-26 |
KR100974770B1 (ko) | 2010-08-06 |
EP1483265B1 (en) | 2006-11-22 |
IL163781A (en) | 2010-04-15 |
WO2003076442A1 (en) | 2003-09-18 |
AU2003215325B2 (en) | 2008-09-18 |
JP2005526072A (ja) | 2005-09-02 |
AU2003215325B8 (en) | 2008-10-09 |
US8022065B2 (en) | 2011-09-20 |
US8058425B2 (en) | 2011-11-15 |
CN1312154C (zh) | 2007-04-25 |
CN1639165A (zh) | 2005-07-13 |
CA2477967A1 (en) | 2003-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL163781A0 (en) | Purine derivatives as kinase inhibitors | |
PT1761520E (pt) | Inibidores de quinase | |
IL163777A0 (en) | Kinase inhibitors | |
IL160915A0 (en) | Indolizines inhibiting kinase proteins | |
UA85505C2 (xx) | Інгібітори кінази$ингибиторы киназы | |
RS79004A (xx) | Nova jedinjenja | |
EA200501928A1 (ru) | Пирролодигидроизохинолины как ингибиторы pde10 | |
IL165515A0 (en) | Bisindolyl-maleimid derivatives as kinase inhibitors | |
TW200728277A (en) | Bicyclic derivatives as P38 inhibitors | |
PL373645A1 (en) | Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors | |
GB0100889D0 (en) | Compounds | |
WO2004031401A3 (en) | Novel tyrosine kinases inhibitors | |
IL173200A0 (en) | Piperidyl-quinazoline derivatives as tyrosine kinase inhibitors | |
HK1086257A1 (en) | Diazepinoindole derivatives as kinase inhibitors | |
AU2003271566A8 (en) | Pyrrolopyrazines as kinase inhibitors | |
TNSN08191A1 (en) | Kinase inhibitors | |
EP1675552A4 (en) | PREPARATION OF 1,6-DISUBSTITUTED AZABENIC ZIMIDAZOLES AS KINASE-INHIBITORS | |
WO2004063151A3 (en) | Novel tyrosine kinase inhibitors | |
EA200801200A1 (ru) | ПРОИЗВОДНЫЕ ПИРАЗОЛИЗОХИНОЛИНМОЧЕВИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ p38 КИНАЗЫ | |
ZA200404752B (en) | 6-aminomorphinane derivatives method for the production and use thereof | |
MXPA05009151A (es) | Inhibidores de cinasa heterociclica. | |
SE0103710D0 (sv) | Compounds | |
TW200628153A (en) | Novel compounds | |
WO2005028474A3 (en) | Pyrazoloquinoline derivatives as chk-1 inhibitors | |
GB0308201D0 (en) | Novel compounds |